Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2023EClinicalMedicineOpen Access

Ketamine for the treatment of major depression: a systematic review and meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

SNStevan NikolinARAnthony RodgersASAndreas Schwaab

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nikolin et al. (2023) studied this question.

synapsesocial.com/papers/6a75eff020e137e1c1163218https://doi.org/10.1016/j.eclinm.2023.102127
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial2017 · 433 citations
  2. 2Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis2015 · 232 citations
  3. 3Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG2018 · 90 citations
  4. 4Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial2017 · 176 citations